Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sidestepping the "Washout," SV Life Sciences Closes $523 Million Fund

This article was originally published in The Pink Sheet Daily

Executive Summary

The dedicated health care fund says it will stick with its formula: half the fund into biopharma, the other half spread among devices, diagnostics, services, and information technology.
Advertisement

Related Content

Shrinking Funding Rounds For European Biotechs Are No Surprise, But Series A Rounds Look Healthy, If Few
Shrinking Funding Rounds For European Biotechs Are No Surprise, But Series A Rounds Look Healthy, If Few
Advent's Life Science Fund Attracts UK Government Backing
Biotech Ventures Forth: Third Rock Rolls Out $426M Fund, Relypsa Reloads
As VC Investments Rebound In Q2, Skepticism Lingers
OrbiMed Closes $550 Million Fund
Biotech Backers Are Learning to Live with Exit-by-Earn-out
Venture Data Continues To Haunt The Biotech Landscape
Venture Data Continues To Haunt The Biotech Landscape
What Dry Spell? 5AM Closes $200 M Fund

Topics

Advertisement
UsernamePublicRestriction

Register

PS070831

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel